|
CSL Behring
1020 1st Ave King of Prussia , PA 19406 https://www.cslbehring.com/ About CSL Behring It began with a promise. CSL Behring's parent company, CSL, was formed more than 100 years ago to save lives using the latest technologies. In the century since, CSL Behring has grown into a global biotechnology leader, driven by that same promise to save and improve lives. We offer the broadest range of quality plasma-derived and recombinant therapies in our industry. Our ability to innovate and deliver life-saving medicines for patients with rare disease and other unmet medical needs around the world has earned us a reputation for always putting patients first. We are CSL Behring and we are driven by our promise. Representative David Karas, Area Manager - Immunology david.karas@cslbehring.com Lynn Tomko, Area Manager - Immunology lynn.tomko@cslbehring.com Bria Gibbs, Area Manager - Immunology bria.gibbs@cslbehring.com Jaclyn Elich, Area Manager - Immunology jaclyn.elich@cslbehring.com Kristine Sambuco, Area Manager - Immunology kristine.sambuco@cslbehring.com Lynne Doebber, Hizentra Patient Advocate Social Media https://twitter.com/CSLBehring https://www.youtube.com/user/CSLBehringGlobal |
Representatives will be available to meet with attendees at the following times:
https://www.hizentra.com/
Hizentra is an IG therapy that provides proven protection for Primary Immunodeficiency (PI) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) with the convenience of self-administration, so you can focus on everyday living. |
